<DOC>
	<DOCNO>NCT02760719</DOCNO>
	<brief_summary>This study evaluate effectiveness nebulized 3 % hypertonic saline solution salbutamol treatment child 2 year , hospitalise acute viral bronchiolitis . Half participant receive nebulized 3 % hypertonic saline solution salbutamol three time daily , half receive standard supportive care , cornerstone bronchiolitis management .</brief_summary>
	<brief_title>The Effectiveness Nebulized Hypertonic Saline Solution Acute Bronchiolitis</brief_title>
	<detailed_description>Acute viral bronchiolitis common low respiratory tract infection infant two year old . Currently effective treatment standard treatment remain supportive care supplemental oxygen correct hypoxia , minimal handle minimise risk exhaustion provision fluid . In recent year study suggest nebulised hypertonic saline , improve airway hygiene , may influence course illness reduce duration hospitalisation without significant side effect . Study protocol : half include patient receive standard treatment bronchiolitis , include supportive care , half additionally receive nebulized 3 % hypertonic saline solution salbutamol ( avoid potential bronchial obstruction ) three time daily .</detailed_description>
	<mesh_term>Bronchiolitis</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<criteria>first episode bronchiolitis : viral low respiratory tract infection sign airway obstruction ( hyperinflated lung , tachypnea , increase work breathing ) crepitation auscultation admission hospital Wang CSS 3 9 randomisation within 4 hour admission history previous episode bronchiolitis/bronchitis primary disease : gastrooesophageal reflux , chronic cardiac pulmonary disease include suspected asthma , immunodeficiency , condition hypotonia severe course bronchiolitis expect newborns premature infant bear &lt; 36 week gestation oxygen saturation &lt; 85 % patient require admission high dependency intensive care unit presentation</criteria>
	<gender>All</gender>
	<minimum_age>1 Month</minimum_age>
	<maximum_age>24 Months</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>3 % hypertonic solution</keyword>
	<keyword>duration hospitalisation</keyword>
</DOC>